LOS ANGELES, May 27, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Moderna, Inc. ("Moderna") (NASDAQ: MRNA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, including eligibility for appointment as a Lead Plaintiff. Click here to join the case via www.portnoylaw.com. Lead Plaintiffs are appointed by the court to act as a fiduciary on behalf of other injured investors. Lead plaintiffs do not bear any direct cost or expense of the case, and are eligible to receive a monetary award for participating in the case.
The investigation focuses on whether the company and its executives misled investors concerning the viability of the Moderna’s lead drug candidate, a vaccine candidate against novel coronavirus. In addition, on May 27th, 2020, Statnews reported that five top executives of Moderna sold more than $89 million of stock this year, thereby directly benefiting from the allegedly misleading statements concerning the company’s vaccine.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising